RenovoRx, Inc. (RNXT) Reports Q1 Loss, Lags Revenue Estimates

RenovoRx, Inc. (RNXT) came out with a quarterly loss of $0.08 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.07 per share a year ago. These figures are adjusted for non-recurring items.A quarter ago, it was expected that this company would post a loss of $0.13 per share when it actually produced a loss of $0.12, delivering a surprise of 7.69%.Over the last four quarters, the company has surpassed consensus EPS estimates two times.RenovoRx, which belongs to the Zacks Medical ...